199 related articles for article (PubMed ID: 25648080)
1. Hyperbaric oxygen therapy (HBOT) suppresses biomarkers of cell stress and kidney injury in diabetic mice.
Verma R; Chopra A; Giardina C; Sabbisetti V; Smyth JA; Hightower LE; Perdrizet GA
Cell Stress Chaperones; 2015 May; 20(3):495-505. PubMed ID: 25648080
[TBL] [Abstract][Full Text] [Related]
2. Might hyperbaric oxygen therapy (HBOT) reduce renal injury in diabetic people with diabetes mellitus? From preclinical models to human metabolomics.
Harrison LE; Giardina C; Hightower LE; Anderson C; Perdrizet GA
Cell Stress Chaperones; 2018 Nov; 23(6):1143-1152. PubMed ID: 30374882
[TBL] [Abstract][Full Text] [Related]
3. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
[TBL] [Abstract][Full Text] [Related]
4. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
[TBL] [Abstract][Full Text] [Related]
5. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
[TBL] [Abstract][Full Text] [Related]
6. Significant association of urinary alpha-1-microglobulin compared to urinary neutrophil gelatinase-associated lipocalin with renal insufficiency in patients with type 2 diabetes.
Chen G; Shan X; Wang H
Nephrology (Carlton); 2021 May; 26(5):400-407. PubMed ID: 33484208
[TBL] [Abstract][Full Text] [Related]
7. Moderate exercise attenuates caspase-3 activity, oxidative stress, and inhibits progression of diabetic renal disease in db/db mice.
Ghosh S; Khazaei M; Moien-Afshari F; Ang LS; Granville DJ; Verchere CB; Dunn SR; McCue P; Mizisin A; Sharma K; Laher I
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F700-8. PubMed ID: 19144689
[TBL] [Abstract][Full Text] [Related]
8. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.
Sedeek M; Gutsol A; Montezano AC; Burger D; Nguyen Dinh Cat A; Kennedy CR; Burns KD; Cooper ME; Jandeleit-Dahm K; Page P; Szyndralewiez C; Heitz F; Hebert RL; Touyz RM
Clin Sci (Lond); 2013 Feb; 124(3):191-202. PubMed ID: 22920224
[TBL] [Abstract][Full Text] [Related]
9. Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.
Zeng XF; Lu DX; Li JM; Tan Y; Li Z; Zhou L; Xi ZQ; Zhang SM; Duan W
BMC Nephrol; 2017 Jul; 18(1):233. PubMed ID: 28701152
[TBL] [Abstract][Full Text] [Related]
10. Urinary oxidative stress markers closely reflect the efficacy of candesartan treatment for diabetic nephropathy.
Yoshida S; Hashimoto T; Kihara M; Imai N; Yasuzaki H; Nomura K; Kiuchi Y; Tamura K; Ishigami T; Hirawa N; Toya Y; Kitamura H; Umemura S
Nephron Exp Nephrol; 2009; 111(1):e20-30. PubMed ID: 19052474
[TBL] [Abstract][Full Text] [Related]
11. Hyperbaric Oxygen Exposure Attenuates Circulating Stress Biomarkers: A Pilot Interventional Study.
Chang JS; Chang E; Lee Y; Cha YS; Cha SK; Cho WG; Jeong Y; Kim H; Park KS
Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33120884
[TBL] [Abstract][Full Text] [Related]
12. The effect of hyperbaric oxygen therapy on kidneys in a rat model.
Berkovitch M; Tsadik R; Kozer E; Abu-Kishk I
ScientificWorldJournal; 2014; 2014():105069. PubMed ID: 25177712
[TBL] [Abstract][Full Text] [Related]
13. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
[TBL] [Abstract][Full Text] [Related]
14. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes.
Sourris KC; Harcourt BE; Tang PH; Morley AL; Huynh K; Penfold SA; Coughlan MT; Cooper ME; Nguyen TV; Ritchie RH; Forbes JM
Free Radic Biol Med; 2012 Feb; 52(3):716-723. PubMed ID: 22172526
[TBL] [Abstract][Full Text] [Related]
15. Early-outgrowth bone marrow cells attenuate renal injury and dysfunction via an antioxidant effect in a mouse model of type 2 diabetes.
Zhang Y; Yuen DA; Advani A; Thai K; Advani SL; Kepecs D; Kabir MG; Connelly KA; Gilbert RE
Diabetes; 2012 Aug; 61(8):2114-25. PubMed ID: 22596053
[TBL] [Abstract][Full Text] [Related]
16. The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study.
Simonson MS; Tiktin M; Debanne SM; Rahman M; Berger B; Hricik D; Ismail-Beigi F
Am J Physiol Renal Physiol; 2012 Apr; 302(7):F820-9. PubMed ID: 22205226
[TBL] [Abstract][Full Text] [Related]
17. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
18. Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.
Maeda Y; Suzuki A; Ishii J; Sekiguchi-Ueda S; Shibata M; Yoshino Y; Asano S; Hayakawa N; Nakamura K; Akiyama Y; Kitagawa F; Sakuishi T; Fujita T; Hashimoto S; Ozaki Y; Itoh M
Heart Vessels; 2015 May; 30(3):362-8. PubMed ID: 24626813
[TBL] [Abstract][Full Text] [Related]
19. Novel urinary biomarkers in pre-diabetic nephropathy.
Garg V; Kumar M; Mahapatra HS; Chitkara A; Gadpayle AK; Sekhar V
Clin Exp Nephrol; 2015 Oct; 19(5):895-900. PubMed ID: 25634253
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective antioxidant effect of alagebrium in experimental diabetes.
Park J; Kwon MK; Huh JY; Choi WJ; Jeong LS; Nagai R; Kim WY; Kim J; Lee GT; Lee HB; Ha H
Nephrol Dial Transplant; 2011 Nov; 26(11):3474-84. PubMed ID: 21478303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
